THOR therapeutics is a research-based biopharmaceutical company, located in Daejeon (Korea), and founded in 2022.
READ MORETHOR
THOR : Take hands for orphan and rare diseases
THOR therapeutics is a research-based biopharmaceutical company which delivers first-in-class therapeutics for the treatment of orphan and rare diseases by unlocking the potential of novel therapeutic targets and mechanisms.
OUR SCIENCE
Connecting expertise across the innovative drug discovery platform.
TARGETS AND PIPELINE
Mitochondrial energy metabolism and novel targets for metabolic,
immunologic and oncologic therapeutics.